| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Radiation Research Laboratory, Department of Radiology [E. W. N. L., F. E. D., T. Y., L. W. O.], and Department of Internal Medicine [B. L. D.], College of Medicine, The University of Iowa, Iowa City, Iowa 52242-1101, and The Institute for Human Gene Therapy, The University of Pennsylvania, Philadelphia, Pennsylvania 19104-4268 [R. Z. J. F. E.]
As a first step in evaluating the tumor suppressor activity of the manganese superoxide dismutase (MnSOD) gene on established tumors in vivo, we used adenovirus-mediated gene transfer as a means of delivering the MnSOD cDNA to hamster cheek pouch carcinoma (HCPC-1) cells in vitro. HCPC-1 cells were transduced with the adenovirus-MnSOD construct (AdMnSOD) at multiplicities of infectivity (MOI) of 0, 10, 25, 50, 100, 150, and 200 MOI or with the adenovirus-LacZ reporter gene construct (AdLacZ) at 100 MOI. Dose-dependent increases in MnSOD immunoreactivity were seen on Western blotting and indirect immunofluorescence microscopy with increasing AdMnSOD titers. Maximal immunoreactivity was observed at 100 MOI AdMnSOD with both techniques. Moreover, we observed a concomitant 6–7-fold increase in MnSOD activity compared with parental cell levels that also peaked at 100 MOI AdMnSOD. To determine the effect of transgene-expressed MnSOD on tumor cell behavior, we examined cell growth, plating efficiency, and anchorage-dependent growth in soft agar. Cell number measured on day 13 decreased approximately 50% with 100 MOI AdMnSOD (P < 0.05) compared with parental cells. Moreover, cell doubling time increased from 38 to 44 h with 100 MOI AdMnSOD. Plating efficiency and cell growth in soft agar decreased approximately two-thirds with 100 MOI AdMnSOD (P < 0.001). These assays of the transformed phenotype in vitro all appeared to show maximal effect with 100 MOI AdMnSOD. As tumor growth in vivo is most predictable by a combination of these in vitro data, our results suggest that if MnSOD can be effectively delivered to a tumor in vivo using the adenovirus paradigm, effective tumor growth suppression can be observed.
1 This work was supported by NIH Grants P50 DE-10758 and P01-CA66081 (to L. W. O.) and a 1R01 DK-51315 Grant (to J. F. E.). B. L. D. is a fellow of the Roy J. Carver Trust. E. W. N. L. is supported by a fellowship award from the Medical Research Council of Canada.
2 To whom requests for reprints should be addressed, at Radiation Research Laboratory, College of Medicine, University of Iowa, B180 Medical Labs, Iowa City, IA 52242-1181.
Received 4/23/97. Accepted 10/29/97.
This article has been cited by other articles:
![]() |
M. L.T. Teoh, M. P. Fitzgerald, L. W. Oberley, and F. E. Domann Overexpression of Extracellular Superoxide Dismutase Attenuates Heparanase Expression and Inhibits Breast Carcinoma Cell Growth and Invasion Cancer Res., August 1, 2009; 69(15): 6355 - 6363. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lu, X. Gong, Y. Lu, J. Guo, C. Wang, and Y. Pan Molecular Cloning and Functional Characterization of a Cell-permeable Superoxide Dismutase Targeted to Lung Adenocarcinoma Cells: INHIBITION CELL PROLIFERATION THROUGH THE Akt/p27kip1 PATHWAY J. Biol. Chem., May 12, 2006; 281(19): 13620 - 13627. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. Oberley Therapeutic Manipulation of the Intracellular Redox State Am. Assoc. Cancer Res. Educ. Book, April 1, 2006; 2006(1): 255 - 258. [Full Text] [PDF] |
||||
![]() |
L. Behrend, A. Mohr, T. Dick, and R. M. Zwacka Manganese Superoxide Dismutase Induces p53-Dependent Senescence in Colorectal Cancer Cells Mol. Cell. Biol., September 1, 2005; 25(17): 7758 - 7769. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-S. Chang, C.-S. Cho, S. Park, S. Yu, S. W. Kang, and S. G. Rhee Peroxiredoxin III, a Mitochondrion-specific Peroxidase, Regulates Apoptotic Signaling by Mitochondria J. Biol. Chem., October 1, 2004; 279(40): 41975 - 41984. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Weydert, B. Roling, J. Liu, M. M. Hinkhouse, J. M. Ritchie, L. W. Oberley, and J. J. Cullen Suppression of the Malignant Phenotype in Human Pancreatic Cancer Cells by the Overexpression of Manganese Superoxide Dismutase Mol. Cancer Ther., April 1, 2003; 2(4): 361 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Cullen, C. Weydert, M. M. Hinkhouse, J. Ritchie, F. E. Domann, D. Spitz, and L. W. Oberley The Role of Manganese Superoxide Dismutase in the Growth of Pancreatic Adenocarcinoma Cancer Res., March 15, 2003; 63(6): 1297 - 1303. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bravard, A. Ageron-Blanc, S. Alvarez, P. Drane, Y. le Rhun, F. Paris, C. Luccioni, and E. May Correlation between antioxidant status, tumorigenicity and radiosensitivity in sister rat cell lines Carcinogenesis, May 1, 2002; 23(5): 705 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Li, T. Yan, J.-Q. Yang, T. D. Oberley, and L. W. Oberley The Role of Cellular Glutathione Peroxidase Redox Regulation in the Suppression of Tumor Cell Growth by Manganese Superoxide Dismutase Cancer Res., July 1, 2000; 60(14): 3927 - 3939. [Abstract] [Full Text] |
||||
![]() |
E.W.N. Lam, H.M. Hammad, R. Zwacka, C.J. Darby, K.R. Baumgardner, B.L. Davidson, T.D. Oberley, J.F. Engelhardt, and L.W. Oberley Immunolocalization and Adenoviral Vector-mediated Manganese Superoxide Dismutase Gene Transfer to Experimental Oral Tumors Journal of Dental Research, June 1, 2000; 79(6): 1410 - 1417. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |